pharma-company /Medicinal products /Active ingredients

Rx · PZN 09002584

LEVODOPA-Benserazid-ratiopharm 200 mg/50 mg tablets

German trade nameLEVODOPA Benserazid-ratiopharm 200 mg-50 mg Tabletten

Active ingredientLevodopa and decarboxylase inhibitorSubstance (DE)Levodopa und Decarboxylasehemmer*Pharmaceutical formTablets

Consistently available

8.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Ambient max. 25 °C

Highest known
purchase price (B2B)

~ €23

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

LEVODOPA-Benserazid-ratiopharm 200 mg/50 mg tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

LEVODOPA-Benserazid-ratiopharm 200 mg/50 mg tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Tablets. One pack size is recorded (PZN 09002584). The pharma availability index for German wholesale stands at 8.5 out of 10 over the past 30 days – the pack was therefore consistently available.

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

More products containing Levodopa and decarboxylase inhibitor

DOPADURA C 100-25 mg retard tablets9.6ISICOM 100 mg/25 mg tablets9.6ISICOM 250 mg/25 mg tablets9.6LEVOCARB 100-25 ret-1A Pharma prolonged-release tablets9.6LEVOCARB 100-25-1A Pharma tablets9.6
All 79 products containing Levodopa and decarboxylase inhibitor →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.